blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2222689

EP2222689 - COMPOUNDS FOR THERAPY AND DIAGNOSIS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  02.02.2018
Database last updated on 14.06.2024
FormerThe patent has been granted
Status updated on  24.02.2017
FormerGrant of patent is intended
Status updated on  20.02.2017
Most recent event   Tooltip06.03.2020Lapse of the patent in a contracting state
New state(s): TR		published on 08.04.2020  [2020/15]
Applicant(s)For all designated states
Prana Biotechnology Ltd
Level 2 369 Royal Parade
Parkville, Victoria 3052 / AU
[2017/13]
Former [2010/35]For all designated states
Prana Biotechnology Ltd
Level 2 369 Royal Parade
Parkville, Victoria 3052 / AU
Inventor(s)01 / BARNHAM, Kevin Jeffrey
142 Reynard Street
Coburg Victoria 3058 / AU
02 / KENCHE, Vijaya
9 Kings Court
Oakleigh East Victoria 3166 / AU
 [2010/35]
Representative(s)WP Thompson
8th Floor
1 Mann Island
Liverpool L3 1BP / GB
[2017/13]
Former [2010/35]Gregory, Robert John H.
W.P. Thompson & Co. Coopers Building Church Street Liverpool
L1 3AB / GB
Application number, filing date08856869.605.12.2008
[2010/35]
WO2008AU01802
Priority number, dateAU2007090666807.12.2007         Original published format: AU 2007906668
[2010/35]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2009070847
Date:11.06.2009
Language:EN
[2009/24]
Type: A1 Application with search report 
No.:EP2222689
Date:01.09.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 11.06.2009 takes the place of the publication of the European patent application.
[2010/35]
Type: B1 Patent specification 
No.:EP2222689
Date:29.03.2017
Language:EN
[2017/13]
Search report(s)International search report - published on:AU11.06.2009
(Supplementary) European search report - dispatched on:EP03.11.2011
ClassificationIPC:C07F17/02, A61K49/06, C07D401/10, A61K31/555, A61P25/28, A61K31/4184, A61K31/4709, A61K49/00, C07D401/04, C07F15/00, A61K51/04
[2011/48]
CPC:
C07D401/04 (EP,US); A61K49/0017 (EP,US); A61K51/0453 (EP,US);
A61K51/0478 (EP,US); A61P25/28 (EP); A61P43/00 (EP);
C07F15/0093 (EP,US) (-)
Former IPC [2010/35]C07F17/02, A61K49/06, C07D401/10, A61K31/555, A61P25/28, A61K31/4184, A61K31/4709
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2017/13]
Former [2010/35]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:VERBINDUNGEN ZUR THERAPIE UND DIAGNOSE[2010/35]
English:COMPOUNDS FOR THERAPY AND DIAGNOSIS[2010/35]
French:COMPOSÉS THÉRAPEUTIQUES ET DIAGNOSTIQUES[2010/35]
Entry into regional phase22.06.2010National basic fee paid 
22.06.2010Search fee paid 
22.06.2010Designation fee(s) paid 
22.06.2010Examination fee paid 
Examination procedure22.06.2010Examination requested  [2010/35]
15.05.2012Amendment by applicant (claims and/or description)
23.07.2013Despatch of a communication from the examining division (Time limit: M04)
21.11.2013Reply to a communication from the examining division
05.01.2015Despatch of a communication from the examining division (Time limit: M04)
14.05.2015Reply to a communication from the examining division
13.04.2016Despatch of a communication from the examining division (Time limit: M04)
20.07.2016Reply to a communication from the examining division
21.10.2016Communication of intention to grant the patent
17.02.2017Fee for grant paid
17.02.2017Fee for publishing/printing paid
20.02.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  23.07.2013
Opposition(s)03.01.2018No opposition filed within time limit [2018/10]
Fees paidRenewal fee
10.12.2010Renewal fee patent year 03
12.12.2011Renewal fee patent year 04
11.12.2012Renewal fee patent year 05
12.12.2013Renewal fee patent year 06
19.12.2014Renewal fee patent year 07
22.12.2015Renewal fee patent year 08
27.12.2016Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU05.12.2008
AT29.03.2017
CY29.03.2017
CZ29.03.2017
DK29.03.2017
EE29.03.2017
ES29.03.2017
FI29.03.2017
HR29.03.2017
IT29.03.2017
LT29.03.2017
LV29.03.2017
MC29.03.2017
PL29.03.2017
RO29.03.2017
SE29.03.2017
SI29.03.2017
SK29.03.2017
TR29.03.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
IS29.07.2017
PT31.07.2017
LU05.12.2017
MT05.12.2017
BE31.12.2017
[2020/15]
Former [2019/46]HU05.12.2008
AT29.03.2017
CY29.03.2017
CZ29.03.2017
DK29.03.2017
EE29.03.2017
ES29.03.2017
FI29.03.2017
HR29.03.2017
IT29.03.2017
LT29.03.2017
LV29.03.2017
MC29.03.2017
PL29.03.2017
RO29.03.2017
SE29.03.2017
SI29.03.2017
SK29.03.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
IS29.07.2017
PT31.07.2017
LU05.12.2017
MT05.12.2017
BE31.12.2017
Former [2019/31]HU05.12.2008
AT29.03.2017
CZ29.03.2017
DK29.03.2017
EE29.03.2017
ES29.03.2017
FI29.03.2017
HR29.03.2017
IT29.03.2017
LT29.03.2017
LV29.03.2017
MC29.03.2017
PL29.03.2017
RO29.03.2017
SE29.03.2017
SI29.03.2017
SK29.03.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
IS29.07.2017
PT31.07.2017
LU05.12.2017
MT05.12.2017
BE31.12.2017
Former [2019/30]AT29.03.2017
CZ29.03.2017
DK29.03.2017
EE29.03.2017
ES29.03.2017
FI29.03.2017
HR29.03.2017
IT29.03.2017
LT29.03.2017
LV29.03.2017
MC29.03.2017
PL29.03.2017
RO29.03.2017
SE29.03.2017
SI29.03.2017
SK29.03.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
IS29.07.2017
PT31.07.2017
LU05.12.2017
MT05.12.2017
BE31.12.2017
Former [2018/50]AT29.03.2017
CZ29.03.2017
DK29.03.2017
EE29.03.2017
ES29.03.2017
FI29.03.2017
HR29.03.2017
IT29.03.2017
LT29.03.2017
LV29.03.2017
PL29.03.2017
RO29.03.2017
SE29.03.2017
SI29.03.2017
SK29.03.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
IS29.07.2017
PT31.07.2017
LU05.12.2017
MT05.12.2017
BE31.12.2017
Former [2018/43]AT29.03.2017
CZ29.03.2017
DK29.03.2017
EE29.03.2017
ES29.03.2017
FI29.03.2017
HR29.03.2017
IT29.03.2017
LT29.03.2017
LV29.03.2017
PL29.03.2017
RO29.03.2017
SE29.03.2017
SI29.03.2017
SK29.03.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
IS29.07.2017
PT31.07.2017
LU05.12.2017
MT05.12.2017
Former [2018/25]AT29.03.2017
CZ29.03.2017
DK29.03.2017
EE29.03.2017
ES29.03.2017
FI29.03.2017
HR29.03.2017
IT29.03.2017
LT29.03.2017
LV29.03.2017
PL29.03.2017
RO29.03.2017
SE29.03.2017
SI29.03.2017
SK29.03.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
IS29.07.2017
PT31.07.2017
Former [2018/09]AT29.03.2017
CZ29.03.2017
DK29.03.2017
EE29.03.2017
ES29.03.2017
FI29.03.2017
HR29.03.2017
IT29.03.2017
LT29.03.2017
LV29.03.2017
PL29.03.2017
RO29.03.2017
SE29.03.2017
SK29.03.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
IS29.07.2017
PT31.07.2017
Former [2017/51]AT29.03.2017
CZ29.03.2017
EE29.03.2017
ES29.03.2017
FI29.03.2017
HR29.03.2017
IT29.03.2017
LT29.03.2017
LV29.03.2017
PL29.03.2017
RO29.03.2017
SE29.03.2017
SK29.03.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
IS29.07.2017
PT31.07.2017
Former [2017/50]AT29.03.2017
CZ29.03.2017
EE29.03.2017
ES29.03.2017
FI29.03.2017
HR29.03.2017
IT29.03.2017
LT29.03.2017
LV29.03.2017
PL29.03.2017
RO29.03.2017
SE29.03.2017
SK29.03.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
IS29.07.2017
Former [2017/49]AT29.03.2017
CZ29.03.2017
EE29.03.2017
ES29.03.2017
FI29.03.2017
HR29.03.2017
IT29.03.2017
LT29.03.2017
LV29.03.2017
RO29.03.2017
SE29.03.2017
SK29.03.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
IS29.07.2017
Former [2017/48]CZ29.03.2017
FI29.03.2017
HR29.03.2017
LT29.03.2017
LV29.03.2017
SE29.03.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
Former [2017/41]FI29.03.2017
HR29.03.2017
LT29.03.2017
LV29.03.2017
SE29.03.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
Documents cited:Search[A]WO2004000814  (MERCK FROSST CANADA INC [CA], et al) [A] 1-15 * page 101; claim 1 *;
 [A]FR2827599  (NEURO3D [FR]) [A] 1-15 * page 7, line 11 * * page 76; claim 1 * * page 86; claim 7 *;
 [A]WO9741856  (MASSACHUSETTS INST TECHNOLOGY [US], et al) [A] 1-15 * page 96; claim 1 *;
 [A]US6696437  (LUBISCH WILFRIED [DE], et al) [A] 1-15 * column 16, line 16 - line 24; example 7 * * column 32, line 1 - line 5; example 108 * * column 37; claim 1 *
 [A]  - BENOIT BACHAND ET AL, "Formal Transfers of Hydride from Carbon-Hydrogen Bonds. Attempted Generation of Molecular Hydrogen by Intramolecular Reduction of Protons Bound by 2,3-Dihydro-1,3-dimethyl-2-(8-quinolinyl)-1H-benzimi dazole", JOURNAL OF ORGANIC CHEMISTRY, AMERICAN CHEMICAL SOCIETY, EASTON.; US, (19870101), vol. 52, no. 24, doi:10.1021/JO00233A026, ISSN 0022-3263, pages 5443 - 5446, XP008136848 [A] 1-15 * page 5443; compound 2 *

DOI:   http://dx.doi.org/10.1021/jo00233a026
International search[A]WO9741856  (MASSACHUSETTS INST TECHNOLOGY [US], et al);
 [A]  - BACHAND, B. ET AL., "Formal Transfers of Hydride from Carbon-Hydrogen Bonds. Attempted Generation of Molecular Hydrogen by Intramolecular Reduction of Protons Bound by 2,3-Dihydro-1,3-dimethyl-2-(8-quinolinyl)-1H-benzimidazole", JOURNAL OF ORGANIC CHEMISTRY, (1987), vol. 52, pages 5443 - 5446, XP008136848

DOI:   http://dx.doi.org/10.1021/jo00233a026
Examination   - Louis Hunter ET AL, "139. The associating effect of the hydrogen atom. Part VIII. The N?H?N bond. Benziminazoles, glyoxalines, amidines, and guanidines", Journal of the Chemical Society (Resumed), (19410101), doi:10.1039/jr9410000777, ISSN 0368-1769, page 777, XP055159424

DOI:   http://dx.doi.org/10.1039/JR9410000777
by applicantFR2827599
 US6696437
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.